Anti Asthma Drug

Product Details:

Emzumab 150mg is a prescription monoclonal antibody injection used primarily to manage severe allergic conditions. It contains the active ingredient Omalizumab and is manufactured by Cipla Ltd.. Medical UsesThis medication is prescribed to reduce the frequency and severity of symptoms in the following conditions: Severe Allergic Asthma: For patients whose symptoms are not well-controlled by standard inhaled corticosteroids.Chronic Spontaneous Urticaria (CSU): Treats persistent hives and itching that do not respond to antihistamines.Nasal Polyps: Reduces inflammation and congestion in chronic rhinosinusitis with nasal polyps.Food Allergies: Sometimes used to reduce allergic reactions following accidental exposure to food allergens. Mechanism of ActionEmzumab works by targeting and neutralizing Immunoglobulin E (IgE), a key antibody that triggers allergic reactions. By binding to IgE, the medicine prevents it from attaching to receptors on immune cells (mast cells and basophils), thereby stopping the release of inflammatory chemicals like histamine. Administration and StorageRoute: It is administered as a subcutaneous injection (under the skin).Dosing: Typically given every 2 to 4 weeks based on the patient's weight and IgE levels.Storage: Must be stored in a cold chain environment between 2°C and 8°C (36°F to 46°F) and should not be frozen.